All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

312

Reset

312 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BLEX 404 LiquidPhase 22 trials

    BioLite, Inc. · Myelodysplastic Syndrome (MDS), Triple Negative Breast Cancer

  • BMS-986158Phase 22 trials

    Bristol Myers Squibb · Myelofibrosis, Multiple Myeloma

  • ImmunityBio, Inc. · Relapsed B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non Hodgkin Lymphoma

  • COH04S1GEO-CM04S1, Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1Phase 22 trials

    GeoVax, Inc. · COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Leukemia

  • CRC01Phase 22 trials

    Curocell Inc. · Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL)

  • CusatuzumabOV-1001, JNJ-74494550Phase 22 trials

    OncoVerity, Inc. · Leukemia, Myeloid, Acute

  • DanburstotugIMC-001Phase 22 trials

    ImmuneOncia Therapeutics Inc. · TMB-H, Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors, Extranodal NK/T-cell Lymphoma, Nasal Type

  • DibotatugDR-01Phase 22 trials

    Dren Bio · Bone Marrow Failure Syndromes, Aplastic Anemias, Severe Aplastic Anemia (SAA)

  • DISC-0974Phase 22 trials

    Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia

  • EmavusertibCA-4948Phase 22 trials

    Curis, Inc. · Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma

  • FeladilimabGSK3359609Phase 22 trials

    GSK · Multiple Myeloma

  • GFH009SLS009Phase 22 trials

    Genfleet Therapeutics (Shanghai) Inc. · Large B-cell Lymphoma, Hematologic Malignancies

  • GNC-035Phase 22 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Relapsed/Refractory Chronic Lymphocytic Leukemia, Non-hodgkin's Lymphoma

  • GW5282Phase 22 trials

    Dizal Pharmaceuticals · T-cell Lymphomas, Advanced Solid Tumors

  • HBI-002Phase 22 trials

    Hillhurst Biopharmaceuticals, Inc. · Parkinson Disease, Anemia, Sickle Cell

  • HH2853Phase 22 trials

    Haihe Biopharma Co., Ltd. · Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL), FL Lymphoma, Epithelioid Sarcoma

  • IDP-121Phase 22 trials

    IDP Discovery Pharma S.L. · Small Cell Lung Cancer ( SCLC ), Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

  • IMGN632Phase 22 trials

    AbbVie · Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm, Acute Myeloid Leukemia

  • LacutoclaxPhase 22 trials

    Guangzhou Lupeng Pharmaceutical Company LTD. · Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma (MCL), Diffuse Large B-Cell Lymphoma (DLBCL)

  • MBS314Phase 22 trials

    Beijing Mabworks Biotech Co., Ltd. · Relapsed or Refractory Multiple Myeloma, Multiple Myeloma

  • OfirnoflastHT-6184Phase 22 trials

    Halia Therapeutics, Inc. · Myelodysplastic Syndromes, Anemia, Myelodysplastic Syndrome

  • parsaclisibINCB050465Phase 22 trials

    Incyte · Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma, B-Cell Malignancies

  • Prizloncabtagene AutoleucelC-CAR039Phase 22 trials

    AbelZeta Inc. · Large B Cell Lymphoma, LBCL, Diffuse Large B Cell Lymphoma (DLBCL)

  • REGN5459Vonsetamig, BCMAxCD3Phase 22 trials

    Regeneron · Chronic Kidney Disease (CKD), Relapsed Multiple Myeloma, Refractory Multiple Myeloma

  • rivogenlecleucelBPX-501 T cells, BPX-501Phase 22 trials

    Bellicum Pharmaceuticals · Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Leukemia, Acute Myeloid (AML), Child

  • SSS17Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Postoperative Anemia, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee

  • STP938Phase 22 trials

    Step Pharma, SAS · Lymphoma, B-Cell, Lymphoma, T-Cell, Essential Thrombocythaemia

  • TebapivatAG-946Phase 22 trials

    Agios Pharmaceuticals, Inc. · Myelodysplastic Syndromes, Sickle Cell Disease

  • TQB3702Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · B-cell Lymphoma, Systemic Lupus Erythematosus

  • TRS005Phase 22 trials

    Zhejiang Teruisi Pharmaceutical Inc. · CD20-positive Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL)

  • YK012Phase 22 trials

    Excyte Biopharma Ltd · Systemic Lupus Erythematosus (SLE), B-cell Acute Lymphoblastic Leukemia

  • AB8939Phase 21 trial

    AB Science · Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndrome Acute Myeloid Leukemia

  • ABBV-2001Phase 21 trial

    AbbVie · Multiple Myeloma

  • ABD-3001DIMATEPhase 21 trial

    Advanced BioDesign · Acute Myeloid Leukemia, Adult, Myelodysplastic Syndromes

  • AG-120Phase 21 trial

    Bristol Myers Squibb · Leukemia, Myeloid, Acute

  • AG-221Phase 21 trial

    Bristol Myers Squibb · Leukemia, Myeloid, Acute

  • ALLO-647Phase 21 trial

    Allogene Therapeutics · Relapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma

  • amsulostatPXS-5505Phase 21 trial

    Syntara · Myelofibrosis, Primary Myelofibrosis (PMF), Post- Essential Thrombocythemia Myelofibrosis

  • AnumigilimabPhase 21 trial

    CSL Behring · Sickle Cell Disease

  • ARD001Phase 21 trial

    Arditus Pte Ltd · Hemophilia A, Healthy Adult Participants

  • ARD103Phase 21 trial

    ARCE Therapeutics, Inc. · Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, MDS (Myelodysplastic Syndrome)

  • ASC618Phase 21 trial

    ASC Therapeutics · Hemophilia A

  • AskBio009BAX 335Phase 21 trial

    Takeda · Hemophilia B

  • ASTX660Phase 21 trial

    Taiho Oncology, Inc. · Solid Tumors, Lymphoma

  • AT101Anti-CD19 Chimeric Antigen Receptor T cellPhase 21 trial

    AbClon · B-cell Non Hodgkin Lymphoma

  • AZD0305Phase 21 trial

    AstraZeneca · Multiple Myeloma

  • AZD3632Phase 21 trial

    AstraZeneca · Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Higher-risk Myelodysplastic Syndromes

  • AZD4045Phase 21 trial

    AstraZeneca · Relapsed or Refractory Multiple Myeloma

  • AZD4512Phase 21 trial

    AstraZeneca · B-cell Non-Hodgkin Lymphoma

  • BAY2599023DTX201Phase 21 trial

    Bayer · Hemophilia A

NewerPage 4 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.